ELIMITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elimite, and when can generic versions of Elimite launch?
Elimite is a drug marketed by Aurobindo Pharma Usa and is included in one NDA.
The generic ingredient in ELIMITE is permethrin. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the permethrin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elimite
A generic version of ELIMITE was approved as permethrin by ACTAVIS LABS on January 23rd, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ELIMITE?
- What are the global sales for ELIMITE?
- What is Average Wholesale Price for ELIMITE?
Summary for ELIMITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 4 |
| Drug Prices: | Drug price information for ELIMITE |
| What excipients (inactive ingredients) are in ELIMITE? | ELIMITE excipients list |
| DailyMed Link: | ELIMITE at DailyMed |
Recent Clinical Trials for ELIMITE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Saptalis Pharmaceuticals | Phase 3 |
| Saptalis Pharmaceuticals LLC | Phase 3 |
| Encube Ethicals Pvt. Ltd. | Phase 3 |
Pharmacology for ELIMITE
| Drug Class | Pyrethroid |
US Patents and Regulatory Information for ELIMITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | ELIMITE | permethrin | CREAM;TOPICAL | 019855-001 | Aug 25, 1989 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
